Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines. - Test2 - elhamkhani - TriplyDB

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

http://www.wikidata.org/entity/Q37184436

about

Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.Attenuated Toxoplasma gondii therapy of disseminated pancreatic cancer generates long-lasting immunity to pancreatic cancer Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.Intratumoral immunotherapy for melanoma.Cancer therapy in a microbial bottle: Uncorking the novel biology of the protozoan Toxoplasma gondii.Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice

P2860

Q35439431-67529926-B187-4A20-89E2-C1F46186D451 Q35920573-F11FBA83-1475-4490-99D4-80A59EF521A8 Q36821108-8BABE464-36D8-4993-828C-F396D38C48E4 Q37119146-717F215B-47C5-4D4D-B78A-9C67C15049D5 Q38518518-B1D518B5-B618-4E17-BF2E-16BA292321C2 Q41068755-257D60C4-EEF0-4C5C-9722-C4D15B7318A6 Q57179393-8B81DAC8-CB0C-452D-9560-4EB7EC5EA5D2

P2860

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

http://www.wikidata.org/entity/Q37184436

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

@en

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

@nl

type

label

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

@en

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

@nl

prefLabel

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

@en

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

@nl

P1433

Q37184436-878D9E30-3A9E-4C78-84F3-CB52FC15FC28

P1476

Q37184436-A745A5FC-EE70-4DF6-8DCC-0743C3E77632

P2093

Q37184436-403F8CF2-E89C-4AFB-89EF-55C04C140ABA

Q37184436-7002AD72-2A83-487E-AF8A-6C801177EBBA

Q37184436-99791C48-F419-47A2-8FE7-55BBF22C68B0

P2860

Q37184436-10AEF5F0-F1BF-4F36-9516-2F6AD550B521

Q37184436-1381C65B-76AC-4383-B19A-382F98580712

Q37184436-15E754BC-992B-4C06-B728-B3116D0CDF26

Q37184436-183E0158-D79C-4D1A-BE82-0C4E04E6D1AC

Q37184436-185309F1-1D81-4E94-B940-60D8DF4A7604

Q37184436-1859651A-1EF5-4509-A21A-FAC47D576311

Q37184436-2898F384-929D-4C1B-B231-A5622A436684

Q37184436-2A7BCB74-11E0-438C-A617-3D8283B5BE6C

Q37184436-2ABB11EB-E831-4D15-B899-CA9451415EFE

Q37184436-2C05953D-AD96-4D89-A3D0-4E4A6932D799

P304

Q37184436-A972C731-D549-4735-9557-B4C1947B468D

P31

Q37184436-076BB17E-0782-45C4-AA51-E3BDC19C371D

P356

Q37184436-1DEFDBCD-3595-4793-8812-DA597E123789

P433

Q37184436-6495C84A-02AD-4CFB-BC7A-E975332CEA92

P478

Q37184436-2B48B393-2DFA-4C28-BB6F-F68AB2F380C5

P50

Q37184436-08B3F472-A7E0-494A-9EB5-BFAEDF791FBD

P577

Q37184436-E7196766-548D-47DC-A6BB-F0C682DE9220

P698

Q37184436-D29FC47F-12BE-4D52-9729-6986B63A675E

P921

Q37184436-F577F9B1-CC57-42A3-91AD-7476B5547C37

P932

Q37184436-A6F85CF7-142D-4278-AA80-C3368F00552E

P356

J.PT.2013.07.001

P1433

Trends in Parasitology

P1476

Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines

@en

P2093

Barbara A Fox

http://www.w3.org/2001/XMLSchema#string

David J Bzik

http://www.w3.org/2001/XMLSchema#string

Kiah L Sanders

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death

Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

Immune response and immunopathology during toxoplasmosis

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Cancer statistics, 2008

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Interleukin-12 and the regulation of innate resistance and adaptive immunity

P304

431-437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PT.2013.07.001

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23928100

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

P932

3777737

http://www.w3.org/2001/XMLSchema#string